Synthesis and Antibacterial Activity of Bis-[1-(Adamantan-1-Yl)Ethyl]Amine Hydrochloride


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

An impurity in rimantadine hydrochloride drug substance that was previously undescribed in regulatory documents and the literature was identified. Its structure was elucidated and confirmed by a convergent synthesis. A method for synthesizing bis-[1-(adamantan-1-yl)ethyl]amine hydrochloride under laboratory conditions was developed. The antibacterial activity of the synthesized compound was assessed.

About the authors

V. I. Krylov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

S. V. Moiseev

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Author for correspondence.
Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

A. A. Kutin

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

N. G. Sakhno

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

O. V. Gunar

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

V. A. Yashkir

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

V. A. Merkulov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies